Adolor cuts 30 jobs as Entereg sales falter

Exton, PA-based Adolor is cutting 30 jobs, or about a third of its workforce, as it attempts to reduce cash burn levels. The developer had 114 employees at the end of 2009. In May 2008, the FDA approved Entereg for postoperative ileus, a common condition following surgery that can extend a patient's hospital stay. It was the first approval for Adolor, which was partnered with GlaxoSmithKline on the treatment. Sales of the drug have been slow since it launched in 2009. Second quarter sales of...